跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要研究多阶段治疗分配规则及其生存收益优化,直接对应动态治疗方案的因果推断方向。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Fei Xue
Yanqing Zhang
Wenzhuo Zhou
Haoda Fu
Annie Qu

利用多类别角度学习估计删失数据下的最优动态治疗方案

研究问题
面对多阶段、多类别治疗及删失生存数据,如何寻找最大化患者条件生存概率的动态治疗规则,而不只优化二元治疗下的平均生存时间?
方法与思路
作者提出角度学习方法,将多个阶段的治疗决策规则估计整合为单一多类别分类算法,以条件生存函数为优化目标处理删失数据。
材料陈述的贡献
摘要称,方法在正则条件下具有 Fisher 一致性与风险界;数值研究显示条件生存概率表现较好,并应用于心脏病和艾滋病数据。
阅读关注点
应核对治疗规则价值的定义、各阶段因果识别与删失处理条件、分类损失和目标的对应关系,以及风险界的具体适用范围。
阅读边界
依据版本未注明的 OpenAlex 索引摘要;识别假设、删失机制和正则条件未说明,Fisher 一致性不能替代因果识别或有限样本效果保证。

原文摘要

An optimal dynamic treatment regime (DTR) consists of a sequence of decision rules in maximizing long-term benefits, which is applicable for chronic diseases such as HIV infection or cancer. In this article, we develop a novel angle-based approach to search the optimal DTR under a multicategory treatment framework for survival data. The proposed method targets to maximize the conditional survival function of patients following a DTR. In contrast to most existing approaches which are designed to maximize the expected survival time under a binary treatment framework, the proposed method solves the multicategory treatment problem given multiple stages for censored data. Specifically, the proposed method obtains the optimal DTR via integrating estimations of decision rules at multiple stages into a single multicategory classification algorithm without imposing additional constraints, which is also more computationally efficient and robust. In theory, we establish Fisher consistency and provide the risk bound for the proposed estimator under regularity conditions. Our numerical studies show that the proposed method outperforms competing methods in terms of maximizing the conditional survival probability. We apply the proposed method to two real datasets: Framingham heart study data and acquired immunodeficiency syndrome clinical data. Supplementary materials for this article are available online.

笔记与分组